Harm Reduction Guide

Harm Reduction and Psilocybin

Harm reduction is a public health approach that acknowledges people use substances — and focuses on reducing the risks associated with that use rather than demanding abstinence. Applied to psilocybin, harm reduction means providing accurate information, preparation guidance, and safety practices that make the difference between a difficult experience and a genuinely harmful one.

Psilocybin has a strong safety profile relative to most substances, including alcohol. It is not physically addictive. Lethal overdose from psilocybin alone has never been documented in the medical literature. But psychological difficulty, dangerous behavior during a session, and lasting distress from inadequately prepared or supported experiences are real risks — and preventable ones.

Know What You Are Taking

The most basic harm reduction principle: know what the substance actually is.

In the underground market, psilocybin mushrooms are sold as dried fungi — the physical form makes identification relatively straightforward, though mis-identification of species does occur. The greater risk is in pressed pills, powders, or gummies sold as "psilocybin" that may contain entirely different substances (NBOMe compounds, other synthetic psychedelics, or no active substance at all).

If you are not sourcing from a licensed Oregon or Colorado facility:

• Drug checking services exist in many cities — organizations like DanceSafe provide fentanyl test strips and other reagent tests
• The Ehrlich reagent test (widely available online) turns purple in the presence of indole alkaloids including psilocybin — a basic confirmation that the substance contains an indole compound
• No at-home test can confirm psilocybin specifically or rule out all adulterants; reagent testing reduces risk, it does not eliminate it

Dosing

Psilocybin potency varies significantly between mushroom batches, strains, and storage conditions. There is no standardized dosing outside of pharmaceutical trials.

General dried mushroom guidelines (Psilocybe cubensis):

| Level | Dose | Experience | |-------|------|------------| | Threshold | 0.1–0.25g | Subtle perceptual shifts, mood change | | Low | 0.5–1g | Mild visual effects, mood elevation | | Moderate | 1–2.5g | Clear psychedelic effects, emotional material surfaces | | High | 2.5–4g | Intense experience, ego softening, therapeutic range | | Very high | 4g+ | Complete ego dissolution possible |

Critical notes:

• These ranges assume average-potency Psilocybe cubensis. High-potency varieties (Penis Envy, Tidal Wave) may be 2–3 times more potent by weight.
• Always start lower than you think you need. You can always take more in a future session. You cannot reduce a dose once taken.
• Eating a full meal before a session reduces absorption and onset speed. Most people find a light meal 2–3 hours before optimal.
• Body weight has a modest but real effect on experience intensity.

Set and Setting

Set (mindset) and setting (environment) are the most powerful determinants of experience quality — more influential than dose in many cases.

Set:

• Approach with intention and openness rather than rigid expectations
• Address acute stress, unresolved conflict, or major anxiety before a session if possible — these will be amplified
• Avoid psilocybin when depressed, acutely grieving, or in personal crisis without professional support

Setting:

• Private, familiar, comfortable space with no unexpected visitors
• Soft, adjustable lighting — harsh fluorescents are not conducive to a good session
• A bed, mat, or comfortable recliner where you can lie down
• A curated music playlist — music is a significant driver of experience quality in clinical settings
• A trusted person present, especially for doses above 2g — this is the most important safety measure

See Set and Setting for a full preparation guide.

The Importance of a Sitter

A sitter is a trusted person who remains sober and present during a psilocybin session. They do not guide the experience — they hold space, ensure physical safety, and provide grounding if the experience becomes difficult.

What a sitter does:

• Stays present and sober for the full duration
• Ensures the physical environment remains safe
• Offers calm, grounding presence if distress arises — a hand on the shoulder, a calm voice, a reminder that the experience will pass
• Does not try to talk someone through the content of the experience or interpret what is happening

What a sitter does not do:

• Intervene in the psychological content of the experience
• Administer additional substances
• Leave for any significant period

For doses above 2g, a sitter is strongly recommended. For doses above 3.5g, it should be considered non-negotiable.

Working with Difficult Experiences

Difficult experiences — commonly called "bad trips" — are not inherently harmful. In clinical research, many of the most therapeutically productive sessions involve significant difficulty. The distress often reflects material that needed to surface. The problem is not the difficulty itself but the response to it.

The STOP protocol:

• Surrender — stop fighting the experience. Resistance amplifies difficulty.
• Trust — remind yourself the substance is temporary and will pass.
• Observe — try to witness what is arising rather than identifying with it.
• Proceed — let the experience move. It is going somewhere.

Practical interventions when difficulty arises:

• Change position — lying down, sitting up, moving to another room can shift the experience
• Change the music — or turn it off entirely
• Go outside briefly if the environment is safe
• Focus on slow, deliberate breathing
• The sitter can offer a hand, water, or verbal grounding: "You're safe, you're with [name], this will pass"

Benzodiazepines (Valium, Ativan, Xanax) will reliably abort a psilocybin experience within 20–30 minutes. Having a benzodiazepine on hand as an emergency option — available only to people with a prescription — is a legitimate harm reduction measure for high-dose sessions, to be used only if the person is in a sustained state of distress or danger. This is not to be used to simply end an uncomfortable experience.

Drug Interactions

The most important interactions to know:

• SSRIs/SNRIs — significantly blunt or eliminate psilocybin effects. Do not abruptly stop SSRIs to use psilocybin.
• MAOIs — potentially dangerous combination. MAOIs can dramatically intensify and prolong effects in unpredictable ways.
• Lithium — combined with psychedelics, lithium has been associated with seizures. This is a hard contraindication.
• Tramadol — serotonin syndrome risk when combined with psychedelics.
• Cannabis — dramatically intensifies psilocybin effects and increases anxiety and paranoia risk. Avoid during sessions.
• Alcohol — avoid in the 24 hours before and during a session.

See Drug Interactions for a complete list.

Contraindications

Psilocybin is not appropriate for everyone. The most important contraindications:

• Personal or family history of schizophrenia, bipolar I disorder, or psychosis
• Current lithium use
• Active MAOI use
• Severe cardiovascular disease (psilocybin temporarily elevates blood pressure and heart rate)
• Pregnancy

People with these conditions should not use psilocybin without direct medical supervision and explicit guidance from a physician familiar with the research.

See Contraindications for the full list and nuanced guidance.

After the Experience

The first 24 hours:

• Rest. Avoid alcohol, cannabis, and stimulants.
• Eat gently — appetite often returns slowly.
• Avoid making major decisions.
• Write down what you experienced and what emerged, even if it doesn't fully make sense yet.

The first two weeks:

• This is the neuroplasticity window. New patterns are more accessible now than at any other time.
• Continue avoiding alcohol and cannabis if possible — they blunt the window.
• Work with what emerged — in therapy, with trusted people, through somatic practices, in nature.
• If significant distress persists beyond 72 hours, contact a mental health professional. MAPS maintains a crisis support line for people in acute distress following a psychedelic experience.

If you had a traumatic experience:

• Contact MAPS Psychedelic Support: maps.org/crisis-support
• Contact Fireside Project: firesideproject.org (peer support for difficult psychedelic experiences)
• Do not dismiss the experience as "just a bad trip" — what surfaced may be worth working with in a therapeutic context

Resources

• Fireside Project: firesideproject.org — free peer support for difficult psychedelic experiences, call or text 62-FIRESIDE
• MAPS Crisis Support: maps.org/crisis-support
• DanceSafe: dancesafe.org — drug checking supplies and harm reduction resources
• TripSit: tripsit.me — online harm reduction chat and drug interaction database
• Zendo Project: zendoproject.org — psychedelic support training and crisis response